-

08:10:58 PM

RCEL Stock News

RCEL - AVITA Medical Inc

09/13/21 4:01 PM

Nasdaq : RCEL

conferences

AVITA Medical to Present at the 2021 Cantor Virtual Global Healthcare Conference

AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet

RHEA-AI

neutral

08/31/21 4:01 PM

Nasdaq : RCEL

conferences

AVITA Medical to Participate at the Lake Street 2021 BIG5 Conference

AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs,

RHEA-AI

neutral

08/26/21 4:01 PM

Nasdaq : RCEL

earnings

AVITA Medical Reports Fourth Quarter and Fiscal Year 2021 Financial Results

AVITA Medical, Inc. (NASDAQ: RCEL, ASX:AVH) ( Company), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, today reported

RHEA-AI

neutral

08/16/21 8:00 AM

Nasdaq : RCEL

fda approval

FDA Approves IDE Amendment to a Single-Arm Design for AVITA Medical’s Pivotal Study of the RECELL® System for Vitiligo Treatment

New single-arm design to evaluate 23 subjects at 15 clinical sites, versus previously approved 3-arm study of 84 subjects The 1:20 expansion ratio to be used is the best-case scenario for patients as it requires the least amount of donor skin VALENCIA, Calif. and MELBOURNE, Australia, Aug. 16,

RHEA-AI

positive

08/12/21 4:01 PM

Nasdaq : RCEL

earnings

AVITA Medical to Announce Fiscal Fourth Quarter 2021 Financial Results

AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs,

RHEA-AI

neutral

06/29/21 4:23 PM

Nasdaq : RCEL

AVITA Medical Announces Inclusion in the Russell 3000 Index

AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs,

RHEA-AI

neutral

06/15/21 6:08 PM

Nasdaq : RCEL

earnings

AVITA Medical Announces Preliminary Fourth Quarter 2021 Financial Results

AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs,

RHEA-AI

neutral

06/10/21 9:00 AM

Nasdaq : RCEL

U.S. Food and Drug Administration Approves Expanded Use of the RECELL® System for the Treatment of Extensive Burns and Pediatric Patients

AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine

RHEA-AI

neutral

06/01/21 4:01 PM

Nasdaq : RCEL

management

AVITA Medical, Inc. Appoints Two New Non-Executive Members to the Board of Directors

AVITA Medical, Inc. (Nasdaq: RCEL; ASX: AVH) (“AVITA Medical”), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for

RHEA-AI

neutral

05/13/21 4:01 PM

Nasdaq : RCEL

earnings

AVITA Medical Reports Third Quarter 2021 Financial Results

AVITA Medical, Inc. (NASDAQ: RCEL, ASX:AVH) (Company), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet

RHEA-AI

neutral

RCEL Data:

IndustrySurgical and Medical Instrument Manufacturing
Websiteavitamedical.com
Security nameAVITA Medical Inc
Issue typecs
SectorManufacturing
Sic code3841
Employees2020
Tags
- Health Technology
- Biotechnology
- Medical Specialties

RCEL Description:

AVITA Medical is a regenerative medicine company with a technology platform positioned to address unmet medical needs in burns, chronic wounds, and aesthetics indications. AVITA Medical's patented and proprietary collection and application technology provides innovative treatment solutions derived from the regenerative properties of a patient's own skin. The medical devices work by preparing a RES® REGENERATIVE EPIDERMAL SUSPENSION, an autologous suspension comprised of the patient's skin cells necessary to regenerate natural healthy epidermis. This autologous suspension is then sprayed onto the areas of the patient requiring treatment.